How many patents does
Metabolex have?
patents
389
families
43
granted
100
applications
289
US
82
EP
48
WO
26
CN
24
JP
14
KR
13
RoW
182
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Metabolex
Top ten assignees appearing on patents
2009 - 2018
| metabolex | 250 |
| cymabay therapeutics | 98 |
| diatex company | 24 |
| janssen pharmaceutica | 1 |
| shimabay therapeutics | 1 |
| camabay therapeutics | 1 |
2009
| metabolex | 40 |
| janssen pharmaceutica | 1 |
| diatex company | 1 |
2018
| cymabay therapeutics | 12 |
| metabolex | 5 |
| diatex company | 1 |
Metabolex
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| gpr120 receptor agonists and uses thereof | 37 | 2008 |
| heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders | 35 | 2006 |
| methods for treating gout flares | 26 | 2011 |
| aryl gpr120 receptor agonists and uses thereof | 24 | 2008 |
| oxymethylene aryl compounds and uses thereof | 22 | 2008 |
| methods for treating gout in patient subpopulations | 20 | 2011 |
| methods for treating hyperuricemia in patients with gout using halofenate or halofenic a… 🛈 | 18 | 2011 |
| substituted tetrazol-1-yl-phenoxymethyl-thiazol-2-yl-piperidinyl-pyrimidine salts | 18 | 2009 |
| use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment… 🛈 | 17 | 1999 |
| process for the stereoselective preparation of (-)-halofenate and intermediates thereof | 17 | 2005 |